E&C Leaders Ask FDA To Share Info About Generic Market Withdrawals

House Energy & Commerce Committee leaders ask FDA to share information about the types of temporary withdrawals it is seeing in the generic drug market and how the agency is monitoring the marketing status of generic drugs. In a letter to FDA chief Stephen Hahn sent Friday (March 6), the lawmakers point to complaints that generic drug makers are temporarily withdrawing products from the market to harm competition and raise drug prices. The lawmakers say they’re aware of concerns that...